PCG Welcomes the Maryland Proton Treatment Center to our membership!
PCG welcomes the Maryland Proton Treatment Center to our membership!
The new center, located in Baltimore, MD, is scheduled to begin treating patients this winter. We are thrilled to be working with this team!
Click below to learn more about the center: http://www.mdproton.com/
PTCOG Abstract Deadline Extended
The PTCOG Abstract Deadline has been extended to February 2, 2016. Please allow 5 business days for processing of any data use requests.
PCG Member Spotlight: Carl Rossi, Jr., MD, Scripps Proton Therapy Center
Dr. Rossi is a board certified radiation oncologist, specializing in proton beam therapy, specifically for prostate cancers and lymphomas and serves as the medical director of Scripps Proton Therapy Center. Dr. Rossi previously served as chief of genito-urinary and lymphoma radiation oncology services at Loma Linda University Medical Center and also served as an associate professor of radiation oncology. During his tenure at Loma Linda, Dr. Rossi treated more than 9,000 prostate cancer patients with proton therapy. Dr. Rossi has published more than 20 peer-reviewed articles, as well as contributed chapters to definitive textbooks on radiation oncology. Dr. Rossi earned his medical degree from Loyola University Stritch School of Medicine in 1988 and did his internship and residency at Loma Linda University Medical Center in radiation oncology. Dr. Rossi currently serves as the PCG principal investigator for Scripps Proton Therapy Center and is a member of both the PCG Genito-Urinary and Lymphoma Disease Site Committees.
PCG Members Team Up with Northwestern Medicine
PCG Members Team Up with Northwestern Medicine and the Northwestern Medicine Feinberg School of Medicine to present “Advances in the Management of Primary and Metastatic Brain Tumors”
PCG Board Member, Dr. Minesh Mehta from the University of Maryland, and PCG CNS committee member, Dr. Vinai Gondi from the Northwestern Medicine Chicago Proton Center, were part of an expert panel that presented on the Advances in the Management of Primary and Metastatic Brain Tumors last night in Chicago.